Consumption of new psychoactive substances in a Spanish sample of research chemical users

Hum Psychopharmacol. 2013 Jul;28(4):332-40. doi: 10.1002/hup.2323.

Abstract

Objective: To know the pattern of use of new psychoactive substances (NPSs) in a Spanish sample of research chemical (RC) users and to deepen the RC user profile and risk reduction strategies employed.

Methods: This study is a cross-sectional survey by means of a specific questionnaire. Recruitment was carried out at music festivals, at non-governmental organizations (NGOs), and through announcements on an online forum. Two RC user profiles were defined, according to whether they search information through online forums.

Results: A total of 230 users participated. The most frequent RCs were hallucinogenic phenethylamines (2C-B 80.0%, 2C-I 39.6%) and cathinones (methylone 40.1%, mephedrone 35.2%). The most frequent combination of RC with other illegal drugs was with cannabis (68.6%) and 2C-B with MDMA (28.3%). Subjects who are consulting drug forums (group 1) use more RC, obtain RC by Internet, and use more frequently risk prevention strategies. Regarding the risk-reduction strategies in this group, users sought information concerning RC before consuming them (100%), used precision scales to calculate dosage (72.3%), and analyzed the contents before consumption (68.8%).

Conclusions: There is a specific RC user profile with extensive knowledge and consumption of substances, using different strategies to reduce risks associated to its consumption.

Keywords: 2C-B; consumption patterns; new psychoactive substances; research chemicals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cross-Sectional Studies / trends
  • Female
  • Humans
  • Illicit Drugs / adverse effects*
  • Male
  • Middle Aged
  • Psychotropic Drugs / adverse effects*
  • Risk Reduction Behavior*
  • Spain / epidemiology
  • Substance-Related Disorders / diagnosis
  • Substance-Related Disorders / epidemiology*
  • Young Adult

Substances

  • Illicit Drugs
  • Psychotropic Drugs